Zenas BioPharma, Inc.
(NASDAQ: ZBIO)

Zenas BioPharma, Inc. is a clinical-stage global biopharmaceutical company, which engages in the development and commercialization of transformative immunology-based therapies for patients. The company was founded by Lonnie O. Moulder Jr on November 12, 2019 and is headquartered in Waltham, MA.

18.400 H

-0.160 (-0.86%)
Range 18.140 - 19.000   (4.74%)
Open 18.560
Previous Close 18.560
Bid Price -
Bid Volume -
Ask Price -
Ask Volume -
Volume 724,825
Value 16,330,410
Remark H
Delayed prices. Updated at 30 May 2026 08:15.
Data powered by
View All Events

Loading Chart...

Please login to view stock data and analysis